Atlas Trials

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct

Clinical trial NCT00789958 · COMPLETED

Trial details

NCT number
NCT00789958
Sponsor
SWOG Cancer Research Network
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Extrahepatic Bile Duct CancerGallbladder Cancer
Start date
2008-12-01
Primary completion
2014-12-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.